DK1968949T3 - Forbedret fremgangsmåde til fremstilling af salte af 4-(benzimidazolylmethylamino)-benzamider - Google Patents

Forbedret fremgangsmåde til fremstilling af salte af 4-(benzimidazolylmethylamino)-benzamider

Info

Publication number
DK1968949T3
DK1968949T3 DK06830756.0T DK06830756T DK1968949T3 DK 1968949 T3 DK1968949 T3 DK 1968949T3 DK 06830756 T DK06830756 T DK 06830756T DK 1968949 T3 DK1968949 T3 DK 1968949T3
Authority
DK
Denmark
Prior art keywords
benzimidazolylmethylamino
benzamides
salts
preparation
improved process
Prior art date
Application number
DK06830756.0T
Other languages
English (en)
Inventor
Georg Zerban
Arndt Hausherr
Rainer Hamm
Gunter Koch
Kerstin Schlarb
Heinz-Peter Schmitt
Bjoern Weyell
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1968949T3 publication Critical patent/DK1968949T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK06830756.0T 2005-12-21 2006-12-20 Forbedret fremgangsmåde til fremstilling af salte af 4-(benzimidazolylmethylamino)-benzamider DK1968949T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061624A DE102005061624A1 (de) 2005-12-21 2005-12-21 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
PCT/EP2006/070034 WO2007071743A1 (en) 2005-12-21 2006-12-20 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides

Publications (1)

Publication Number Publication Date
DK1968949T3 true DK1968949T3 (da) 2011-01-24

Family

ID=37950582

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06830756.0T DK1968949T3 (da) 2005-12-21 2006-12-20 Forbedret fremgangsmåde til fremstilling af salte af 4-(benzimidazolylmethylamino)-benzamider

Country Status (23)

Country Link
US (1) US7880016B2 (da)
EP (1) EP1968949B1 (da)
JP (1) JP5317702B2 (da)
KR (1) KR101411961B1 (da)
CN (1) CN101346355B (da)
AR (1) AR058571A1 (da)
AT (1) ATE485279T1 (da)
AU (1) AU2006326980B2 (da)
BR (1) BRPI0620150A2 (da)
CA (1) CA2632310C (da)
CY (1) CY1111113T1 (da)
DE (2) DE102005061624A1 (da)
DK (1) DK1968949T3 (da)
ES (1) ES2355045T3 (da)
IL (1) IL192242A (da)
NZ (1) NZ569636A (da)
PL (1) PL1968949T3 (da)
PT (1) PT1968949E (da)
RU (1) RU2425827C2 (da)
SI (1) SI1968949T1 (da)
TW (1) TWI411608B (da)
WO (1) WO2007071743A1 (da)
ZA (1) ZA200804198B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US7767589B2 (en) * 2007-02-07 2010-08-03 Raytheon Company Passivation layer for a circuit device and method of manufacture
US8173906B2 (en) * 2007-02-07 2012-05-08 Raytheon Company Environmental protection coating system and method
KR20100129281A (ko) * 2008-03-28 2010-12-08 베링거 인겔하임 인터내셔날 게엠베하 경구 투여되는 다비가트란 제형의 제조 방법
JP5642670B2 (ja) * 2008-06-16 2014-12-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランの合成の中間体の製造方法
DK2297132T3 (da) * 2008-06-16 2015-05-26 Boehringer Ingelheim Int Fremgangsmåde til fremstilling af et mellemprodukt af dabigatran-etexilat
JP2011527318A (ja) 2008-07-14 2011-10-27 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランを含有する医薬組成物の製造方法
CA2738883A1 (en) 2008-11-11 2010-05-20 Boehringer Ingelheim International Gmbh Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
US20130149346A1 (en) * 2010-03-08 2013-06-13 ratiopharm GmbH Graf-Arco-Strasse 3 Dabigatran etexilate-containing pharmaceutical composition
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
WO2013150545A2 (en) * 2012-04-02 2013-10-10 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
IN2015DN01414A (da) * 2012-08-31 2015-07-03 Ranbaxy Lab Ltd
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
WO2014068587A2 (en) * 2012-10-29 2014-05-08 Biophore India Pharmaceuticals Pvt. Ltd. An improved process for the synthesis of dabigatran and its intermediates
CN103275065A (zh) * 2013-05-30 2013-09-04 上海同昌生物医药科技有限公司 一种新的生产达比加群酯的方法
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
US10112901B2 (en) 2014-07-03 2018-10-30 Shanghai Institute Of Pharmaceutical Industry Method for preparing dabigatran etexilate intermediate, and intermediate compound
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104987323B (zh) * 2015-07-10 2017-08-22 浙江美诺华药物化学有限公司 一种达比加群酯的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
TWI248435B (en) 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE19962329A1 (de) * 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
PT1485094E (pt) * 2002-03-07 2012-10-09 Boehringer Ingelheim Int Forma de administração por via oral para 3-[(2-{[4- (hexiloxicarbonilamino-imino-metil)-fenilamino]-metil}-1-metil- 1h-benzimidazole-5-carbonil)-piridin-2-il-amino]-propionato de etilo ou os seus sais
NL1026498C2 (nl) * 2004-06-24 2005-12-28 Free Lift B V Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid.
EP1609784A1 (de) 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen

Also Published As

Publication number Publication date
TWI411608B (zh) 2013-10-11
DE102005061624A1 (de) 2007-06-28
CY1111113T1 (el) 2015-06-11
ZA200804198B (en) 2009-04-29
CN101346355B (zh) 2012-09-05
RU2008129637A (ru) 2010-01-27
JP2009520766A (ja) 2009-05-28
EP1968949B1 (en) 2010-10-20
IL192242A0 (en) 2008-12-29
CA2632310C (en) 2014-02-11
TW200740791A (en) 2007-11-01
US20070185173A1 (en) 2007-08-09
AR058571A1 (es) 2008-02-13
EP1968949A1 (en) 2008-09-17
IL192242A (en) 2012-02-29
US7880016B2 (en) 2011-02-01
CA2632310A1 (en) 2007-06-28
KR20080081179A (ko) 2008-09-08
ATE485279T1 (de) 2010-11-15
AU2006326980B2 (en) 2012-07-05
NZ569636A (en) 2010-04-30
WO2007071743A1 (en) 2007-06-28
RU2425827C2 (ru) 2011-08-10
PL1968949T3 (pl) 2011-04-29
CN101346355A (zh) 2009-01-14
DE602006017743D1 (de) 2010-12-02
BRPI0620150A2 (pt) 2011-11-01
SI1968949T1 (sl) 2011-02-28
AU2006326980A1 (en) 2007-06-28
ES2355045T3 (es) 2011-03-22
PT1968949E (pt) 2010-12-22
KR101411961B1 (ko) 2014-06-27
JP5317702B2 (ja) 2013-10-16

Similar Documents

Publication Publication Date Title
DK1968949T3 (da) Forbedret fremgangsmåde til fremstilling af salte af 4-(benzimidazolylmethylamino)-benzamider
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2010498T3 (da) Syntese af acylaminoalkenylenamider, der kan anvendes som substans P-antagonister
ZA200804030B (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)benzamides and the salts thereof
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1651622T3 (da) Fremgangsmåde til fremstilling af 2-(quinoxalin-5-ylsulfonylamino)-benzamidforbindelser
DK1877232T3 (da) Fremgangsmåde til behandling af træoverflader
DK1945631T3 (da) 4- (3-aminopyrazole) pyrimidinderivater til anvendelse som tyrosinkinaseinhibitorer til behandling af cancer
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2029524T3 (da) Fremgangsmåde til fremstilling af 2-[4-(3- og 2-fluorbenzyloxy)benzyl-amino]propanamider
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK1711481T3 (da) Fremgangsmåde til fremstilling af 2-aminothiazol-5-aromatiske carboxamider som kinaseinhibitorer
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK1948176T3 (da) Diarylurinstoffer til behandling af pulmonær hypertension
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK2358691T3 (da) Fremgangsmåde til fremstilling af piperazinforbindelser og hydrochloridsalte deraf
DK1843977T3 (da) Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
DK1963251T3 (da) Fremgangsmåde til fremstilling af aminer
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1682543T3 (da) Fremgangsmåde til fremstilling af nye tiotropiumsalte
DK2215050T3 (da) Fremgangsmåde til fremstilling af 2-hydroxy-5-phenylalkylaminobenzoesyrederivater og salte deraf
DK2402306T3 (da) Fremgangsmåde til fremstilling af 5-aminolaevulinsyrehydrochlorid
DK2366393T3 (da) Roflumilast til behandlingen af pulmonal hypertension